Biomarker Testing Service from Biomedica

for  ELISA and Luminex Assays and microRNA Analysis

With more than 30 years of expertise in the development and manufacturing of ELISA assay kits, Biomedica offers analytical testing services tailored for universities, clinical centers, as well as pharmaceutical and biotechnology industries. Our comprehensive range of analytical solutions ensures that we can provide exceptional service for your research or product development needs.

Biomarker Testing Service from Biomedica

Our highly trained staff will help you to achieve your specified goals and requirements. Biomedica has established a systematic process that guarantees results aligned with your exact specifications. Client satisfaction is our top priority. Having contributed to numerous successful research projects and publications, you will benefit from our expertise in analytical testing, paired with a customer-focused approach.

We offer:

• CUSTOMIZED Services – flexibility to meet your project needs
• EXPERTISE – trained and experienced laboratory staff
• QUALITY ASSURANCE – quality equipment adhering to strict quality guidelines
• TIMELINESS – rapid turn-around times to meet your deadlines
• RELIABILITY – verified and comprehensive results presented in an analytical report

 

Quality Assurance
We are committed to achieving the highest quality standards, recognizing that this is essential for both your success and ours. Our robust quality assurance system, quality control procedures, and testing methods clearly reflect this commitment. We hold ISO 9001:2015 quality management system and with 30 years of experience in the development and manufacturing of immunoassays, we offer expert knowledge and techniques that align with European quality standards.

Our Quality Assurance (QA) system is founded on comprehensive and well-structured standard operating procedures, ensuring that all analyses are traceable from the receipt of samples to the reporting of results. Regular inspections by regulatory bodies further affirm our strong compliance with current regulations.

• Routine internal audits and inspections
• Data assessed for traceability, integrity, and reliability
• Inspections to ensure adherence to protocols and laboratory SOPs

 

Find out more about our workflow for ELISA and Luminex and microRNA Services

Our analytical services include:  

ELISA (Enzyme Linked Immunabsorbent Assay) Kits

We offer services for our proprietary Biomedica assays (product catalogue) as well as ELISA Assay Kits from other suppliers, covering a wide range of biomarker analytes.

LUMINEX Technology Multiplex Assays

We utilize Luminex xMAP® (multiple analyte profiling) technology-based immunoassays to measure your samples, enabling the simultaneous detection and quantification of multiple biomarkers.

For additional details, please refer to our workflow chart or reach out to us directly to discuss how we can support your specific research project. 

NEXT-GENERATION SEQUENCING & RT-qPCR MICRO RNA SERVICES

We provide a comprehensive range of high-quality RNA services, including RNA extraction, next-generation sequencing (NGS), RT-qPCR, and custom analysis of microRNA signatures, all performed by our experienced laboratory staff. Our services include:

• RNA extraction from biofluids (serum, plasma, extracellular vesicles), cells, and tissues (quality control of total RNA utilizes Bioanalyzer chips).
• Next-generation sequencing (NGS).
• RT-qPCR
• Cell-type specific microRNA/mRNA analysis in complex tissues, along with custom analysis of microRNA signatures.

 

Share the details of your project with us!

For more details about our microRNA services, please visit our website or contact us directly (info.at.bmgrp.com).

 

Further reading

High-throughput proteomics: a methodological mini-review. Cui M, Cheng C, Zhang L. Lab Invest. 2022 Nov;102(11):1170-1181. doi: 10.1038/s41374-022-00830-7. Epub 2022 Aug 3. PMID: 35922478; PMCID: PMC9362039.

Circulating miRNAs in bone health and disease. Grillari J, Mäkitie RE, Kocijan R, Haschka J, Vázquez DC, Semmelrock E, Hackl M. Bone. 2021 Apr;145:115787. doi: 10.1016/j.bone.2020.115787. Epub 2020 Dec 8. PMID: 33301964.